Artwork
iconShare
 
Manage episode 482848536 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

touchFOCUS for touchRESPIRATORY

In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC.

The expert:

  • Dr Christine Bestvina - University of Chicago, Chicago, IL, USA

This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchrespiratory.com

  continue reading

522 episodes